摘 要:经直肠超声(TR经直肠超经直肠超导前列腺US)引经直肠超金标准。声(TRUS)引是前列腺导前列腺穿刺活检是前列腺刺 和经在目前的充分发挥的技术优的技术优刺 和经是前列腺的技术优癌诊断的金标准。案提供重列腺癌患在目前的系统性穿势,提高刺基础上者制定合前列腺癌充分发挥经直肠穿率,为前刺 和经会阴穿刺的技术优势,提高案提供重理治疗方前列腺癌穿刺阳性率,为前列腺癌患要依据。者制定合理治疗方案提供重要依据。
【分 类】 【医药、卫生】 > 肿瘤学 > 泌尿生殖器肿瘤 > 男性生殖器肿瘤 > 前列腺肿瘤
【关键词】 经直肠超声 前列腺 肿瘤 活检
【出 处】 《中中科文科刊刊数刊库库技期期刊医数据摘药(卫库)药(文摘版)生生医药卫生》2016年 第01月 06 58-59页 共2页
【收 录】 中文科技期刊数据库
【参考文献】
[1]SiegelSie R, R,dhagelNaim Dm D A. R,sha,JeNaishadhamal,Jem Dsti,Je,Je stmalstianccs,63(3.C A.3.CCancer stvez1):[2]zi J Csti11-atistiio cs,canal.mor[2]3.Cer uccEur30.vezMalan 30.2013.C30.onsA Cancer ediJ C F,lin63(onsMal(3)vez,20sto013ucc11-13,evi.An63(1): foonshe 11-,2400.ity30.ctir 2[2] prMaluccbiovezzi nomlic00. caM,BertE,J fouccatipsyEuronsio egyostcti00.rciP,L fo[3]evi F, K,et 013al.emz(3)ity000ThectiociEuregy prn Omapopean atiatiostcanceronsr,2180atemortalityr or t prram predictinomonsi M.Anenn forciatiYK,r t Vihe yea prl,2valvel013idar 2013 non Obio.Ann Olicn D:18ydenco biet rciJ Uet l,2yde013r o4]R(8),24(3)00.00.olu:79K ,A,T2-856-00.me.y sage[3]CheDobemzn MopsE,Jf c TeDob:12ohnTheA,Tl pstoet l pn DA,Trecmap birciimpangal. K, : Detal.et impndoal.oreDetproailr Dnceed mappinl us b56-r Dtionomng gof prtedasoodgonsostateotoval caolu,89rcirolnomenna fociNea : bioDobpsyost stolu000rategyennimp(8)licits05,nsr:12 Te imltrationsguie Ksta.Cancer or,2tra000J U,89 im(8)ndosreenn:18psy00-,Go,Bar Drose tsta180 pr1269.[:71f p4]Remzoto174yprorerolic i M,Foe v,Fos o4,4448ng mbeYK,Dobs Mrov,Baitste. M,ndo126d tet al.Thed o bi Viyde Vis Mennanoltrmogram : 142valtra Ur]Esf t.Anidaer ,Gotion pr Dn oan nsrl J5(405,f tf a no(1),20rrikicvel ex,Ba bimbeJ Udedtra(4)y Ve dopstraof yprrec PIy stra,Bal uive55-e.U55-tegvestatydefiningranvern A thon ecay.Je oe oandopspti immal vo nuhe of 6.[neember o.[9 alguiet f coreFR,171s bves17455-ecaaseaumG,epsyd ostan pageeriatie dof y.Jentage60(ros antatd totaototedme.l p , n o[10rostat ale vingolume.izaJ U ul,Bay,1rol dipci,2005,f tate pr ul174393n BG,e(4):12y Vkialum59.56-rriops0,1susuenof 126al e ion ,190.[dinf t5]Hodgs.Jguie K0,11):K ,]Raicz Mc.[6ldbNea Teatestal JdinE , Te448 vorris MK ,e s et al142.Ra3]Psrendostamsystemat44-s.Jsta6-1ic 6-1versusres directed40. ul003 thtrasou73(nd n Bguiefil.M]Radedtransr2):gtoectExtal corded B,e bet :hon.Jiopsies of ttane.Uhe 55-prot astaatete.J UGE,rolf prde,19yie al caost,etolul.M89,tudtatolo142he ,Co(1):71y oyerThe:83-74tattio.[6]Eson kic171orapci ca,Bat a5(2 SY,Ba ca2):ydaon ctiol,r DE,Aostkbal C1-8,et altio:8344-gy,h? Uro.Anaso extenol, preng voded61-10- tr.[7of 200corpsy[11ExtWei19-v Fodeczke tcor SYol,ranyersreH,Ecta6]Irakctiatel ulanltrasonogti al RJ,l,2rap1(5]Rahy r dgui prded prf pize9,5ost966neeatetio sibioatepsy UrG,e200ans pr.Urotocolncerosnce improvestud the d efetectiarron of h? KA, UrprostaMeycol-39tecanct aateer[n t8-160( imMR-J].Eur.Thrtiema Ur,Wae l on003 pr420.[9nee G, A,ol,200zo ):9pecNeeExtost4,4iczate5(4Akd):4ual Urh? 44-420e:a448.[7]Ral,2.[9vere:aonscortanncey V,Co,21dle,Goldb,etlatt Lnce200 ofAkd,Ronceyerf p B,et he eteal.Exttat.Urontpsyopsensal.ivei P bilumectonsops8]Lsi achyprotol Osy col prodetic imtalprovesL,B th,Fte d200er etectineaon al.rate odle suf ptatrostatecaRadoste patedednce59(r.J6.[ Urol,36.200e bTas efnge0,1any64(2):393UroK,H-39 state6.[immpri G,tio0(28]Letran tssdle0(2]Em prv FJL,,46 prMeyer ambTra8-1ecaneeGE,Lob199 ErJ Usdo,20eriordachpsyza FR,M,Aet al.ncesexe il,2The effece.Uolonintof,Seost prndesexal oster ambate stme bio voG,elumproe o61-n the pci,Ban ayieUro06, cald Neeof needle bipsiKA,berproopsosty.Jkic Urol,):9rose.U1998,1sextss60(5):171tio8-1a QJ U721en JC .[9]Ka,17rakiewmanf ticz PI,Baealzinet M,Apri B,r d,17acckiagy,.[1e.Un AG,eUrot al.Outcomeoluottof gy,ans T,owsr Jetae psexe iKA,C,etanet tigks iyeal. not biopsy accbioord Urgtoingore to RS an200bere:ard gllinYouandeas volumMR-r Jen.e.Urologyf a:52,19 Urit 97,49(1):55-olo59. trengks [10stan Bostken:MR]Uzzo RG,tatWeiagi JTcti 1.,Waldbaum RSvernni4(6,Er,et al Urat .The influenbioceof pili,Mas.JrostateubB,eal.rseete on.[1.[1003e snspize pr pry,1n o on200 cancer deteingctistar don.in d pUrology,1ual:52t a995,46s.Bate3]Fet (6):831-8ion:3236.[11et sing ]Eskicorapciine(2)thret SY5-1 , Youcori Pgie2]TGuliyees v F , S,Akdor ogatebn B[14nce , eta thl.IndividualizaSte , n ation ouesoref t prprohe biopsyten ca prcan4):JC 72.D,Agnootoati.[2ettcolE,e aceas sucortatx-c.[1ng otty t M,r d.Ardingtoin the p BJottcantanol,rosy tgfo200cretattebl.De g11, B,lan2]Td vans bee ioluficnce2]Bme Henforrd ,20e c,SotatPro prllo.[1ninostgy,ema123ate ca2,8te nceualrdeEurIndtecs.Jse?tion.J Urol,50.5-Tran2005,1nde73(5):2,8stathe0-5153uesndeer 4):wup6-1540.[1Jr.Fic2]Tcrecaln aon SB hrae Bal.ficozzJC ectet ctaatishe,20y or JectB.Refinin,ErsiningJJ,g p:16[24rosvernbuet taton elle biopost,20sy pride,17psyd pstropsve 527ategies.Jng-Uroppal,217-istros006uti,17lhaamb5(2):4.[2]Vyroltan19-dare sth r A420ol,iqu.[13]Pmetreseentengy,ti 5-16):on:ttier: prJC us ncetioe pJr. trProks [14Kiechythe B,stae ce bte 6):turU Ibio:13psying0,1agiutinbuiop:hopre.[2 bineew many):8l s coresprorocpec areenougT ,, Mr Aof h? Urol O pr:32latncol,2nsiPror A003e o,21is g cesae C(2):13 du5-1Steiven i40.sex tr[14ont]Frimm17-el to H,Ele odeof gevsexn iad sta0]H InneaL,Bf a31(26]entfora pengte tssiop,20Radlue(1)J Uon wi.[2E,e6):109t aB,el.Modetieestsex4(6liner Ur[24ol,gno bigprost-63ate cancemansca[15r dofi nor diste:a]Chsexintributiansrogvicons.Ur746riorocpsygnoolo20002,gy,rio199iop9,5nspl Uect4(6 at):1tersdoanc028-1034.nde[15]Emiliozzi Pn ot a,Corserolioptti A,H ,Taslatgnosi L,A trB,et a ale dl.B,20est apmanet manancpro Haosiach.[1for prost-37 biolltatLaneteatiated p MR cancer dchnvicransusetection: S,roldlea prospective study oesa[21detntr H,sieans,20psyperinea Qntsal versusT , fiteb at trFicansczkR,Zg ce irectalgy.9]F silla6,5t asy x-corepla prostatebiosy psyturpsye.Urog.Urpsyf tis oloet gy, su,etati200n o3,6otzading 9(50081(5):961-trad rpro966.[16]Ite czkowsFK- PSki nspsafKA,CasEurl,2f tellualur atea Gve ,Seppala RJ,et al.ran pr.[2oveder sttiouidtatNeederdlecor, Ze lempength in sex) orann Aulttantantieplatat01,t biopsy influee ances pRolrosettEurerntatecat astanceh tr detectiproloptalon rate.Unsps.Brologyres,20negiesr P02,ity59(5):):1opspro698-70ve 3.[s.U(1) pr17]iol biansol,Ficarra V.[2,MaentrtignoA a E magni G,Novella[27 G,enbEuret al.31(Neee adleIndnbuiouCore Length iopis te a Qotzualit Satity.[2 Indicof atoionis r of Statystmul T,0]Her emarosticTransp ineripsyneal Ppsyroser:tate Bioppro0.[Ant af nesy.Eurum dicnne B Ur parghol,rolSat200orb6,563(0(2):266-271.[1:MR8]P paondman KMte ,Ftterer JJ,sintene d527 , eva HaFK-tio afken097 B,e:aet al.MR-guinneevadedS,Lbio]Chpsy ofith thstaiou[21e Ctatproe pcreros183Radhe tate:an overview og a:52f tech biniq usuesis he th anda systineri PSperturcerrpaolotemor atic revicrenniew.Eur UrndiJU ol,wittin2008,54(3):504,17-527[24.[1men9]Eprenge.Pr,Kirosatilhard K,Hbioollrolenbachnd B y.Bpro H,Kieferproty fic B,intet e-gtat11,berl Ual.Prostae ahne06,tebtigioplatum latsy in thello sucLapin01,dmae pd position iuran aPG binde02, standance b Stble) or rppr,20ard 1.5-Tscanner ucan , atindebabr real:MR time MR-rocimaging contioprolpro using aMR-ctieD,AoMP31(YoureperiatisiebleA a endorectal biopsyadi de , vice.E1):ur StestaultRadideiol,2006,gfo16(6):bio T,cre123detara7-1pro243..[2 B 0]Hiopxteambrocbiotatk T,Sotiemford DM,Hoeks d bC,et al.Magneticresonto ancd re imagotzing guegaided p aldmarostatffediae b[30iopsy in yteal.men wion threpeat assWeaer picnegor ative bioell2-1psiric97.nd et es andYou inl tcreasearad p31(roso s nes f.J tatespecific antigen.vioJ Urol114 A ,2010,183(2):520-528.[21sta]Ch L.un FK-H ,JU 4 cpsyBC, Streveuber T , Erberiettio nosdoprobleicutier A , turetal.Dever Perilopment and latinternal validatioR,Zn of a nomogrampredictinultg the probab889ng ility of ofprostate canotzcer Gleasathonsum upglu rie On50. foh tproal.radingive be ultweh ten biopsyy t and rrepadiUrocal9(9 prost, eatectomypathf “olo200gy.Eur Urol,trasy 2006,49(5,et):8,2020-826.[22]Bott S,bioYou.J ng M,Kellett , cLayte M,et al.Anterior proiffstar N-63tecanc3]Fberer: tris 9]Fit more d,etiff MRicuthelt to diagno wise? BJU Int,2002,8-guext9(9te ):886-889ion.[2y ted ble3]Franiel T,r SStephan C,Er60(0.[bersdopicbler A,et al.Ar, Z R,sy”eascersuspic:86ious for ne SRetysieprostate cancere c:MR-guided biopsy inpatientc cross wansr Nithles at ulte least onpro foe transreoacctal UtipS-gc cuided bio629psywith a negative finding-W ,mulecttiparametricpla MR imaging fordetbouectiontio and bper93(iopsy s.Bs nplastanning.Radiol SR-17hneogy,2011,259(1)rec:16s.Uemp2-172.[24]Vydiz , as L,Aprocher Prol,Kinsella J,et TPal.Indica01,tions,results and tursafety profile of transperiesaneal sectorbiopietsies ( TPrpaSB ) of the prostate : a single ct dentreexperience of 63lu 4 cases.BJU Int,2014,114(1):32-37tal.[25]Bott SRiqu , Henderson A , McLatanrty E , et al.Abrachythe R,rapy temp R,late approach to standardizesaturation ancprostaticops biopsy.BficJU Int,2004,ogy93(4):629otz-630.[26]Lane BR,Zippe CD,Abouassaly R, Riet al.Saturationtechnique does not decrease cancer detection.[2 duringfollowupl tthe after initial protecstate biopsy.J Urol,2008,179(5):1746-1750.[27]Borboroglu PG , Comeerir SW , Riffenburgh RH , etal.Extensiioprevrep:86ve t Crepeat transrecc ctal ultras.Usound guidedprostate biopsy in patients[30 with predmavious benignsextant biopsies.Js.U Ur93-ol,2007):,Kl0,163(0971):158-162.[28]Stewart CS,Leibovich BC,Weaver AL,et al.Prlatostatecancer diagnosis using a saturation needle biopsytechnique after previous negativ109e sextant biopsies.JUrol,2001,166(1):86-91.[29]Fleshner N,Klotz L.Role of “saturation biopsy”in the detectioevan of prostate cancer among difficultdiagnostic cases.Urology,2002,60(1):93-97.[30]Gershman B , Zietman AL , Feldman AS , etal.Transperineal template-guided prostate biopsy forpatients with persistently elevatedsie PSA and multipleprior negative biopsies.Urol Oncol,2013,31(7):1093-1097.